Your browser doesn't support javascript.
loading
TIM-3+ CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies.
Minnie, Simone A; Waltner, Olivia G; Zhang, Ping; Takahashi, Shuichiro; Nemychenkov, Nicole S; Ensbey, Kathleen S; Schmidt, Christine R; Legg, Samuel R W; Comstock, Melissa; Boiko, Julie R; Nelson, Ethan; Bhise, Shruti S; Wilkens, Alec B; Koyama, Motoko; Dhodapkar, Madhav V; Chesi, Marta; Riddell, Stanley R; Green, Damian J; Spencer, Andrew; Furlan, Scott N; Hill, Geoffrey R.
Afiliação
  • Minnie SA; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Waltner OG; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Zhang P; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Takahashi S; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Nemychenkov NS; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Ensbey KS; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Schmidt CR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Legg SRW; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Comstock M; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Boiko JR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Nelson E; Department of Pediatrics, University of Washington, Seattle, WA, USA.
  • Bhise SS; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Wilkens AB; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Koyama M; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Dhodapkar MV; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Chesi M; Department of Hematology/Medical Oncology, Emory University, Atlanta, GA, USA.
  • Riddell SR; Winship Cancer Institute, Emory University, Atlanta, GA, USA.
  • Green DJ; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ, USA.
  • Spencer A; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Furlan SN; Division of Medical Oncology, University of Washington, Seattle, WA, USA.
  • Hill GR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Sci Immunol ; 9(94): eadg1094, 2024 Apr 19.
Article em En | MEDLINE | ID: mdl-38640253
ABSTRACT
Chronic antigen stimulation is thought to generate dysfunctional CD8 T cells. Here, we identify a CD8 T cell subset in the bone marrow tumor microenvironment that, despite an apparent terminally exhausted phenotype (TPHEX), expressed granzymes, perforin, and IFN-γ. Concurrent gene expression and DNA accessibility revealed that genes encoding these functional proteins correlated with BATF expression and motif accessibility. IFN-γ+ TPHEX effectively killed myeloma with comparable efficacy to transitory effectors, and disease progression correlated with numerical deficits in IFN-γ+ TPHEX. We also observed IFN-γ+ TPHEX within CD19-targeted chimeric antigen receptor T cells, which killed CD19+ leukemia cells. An IFN-γ+ TPHEX gene signature was recapitulated in TEX cells from human cancers, including myeloma and lymphoma. Here, we characterize a TEX subset in hematological malignancies that paradoxically retains function and is distinct from dysfunctional TEX found in chronic viral infections. Thus, IFN-γ+ TPHEX represent a potential target for immunotherapy of blood cancers.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article